Davis Polk advised the joint book-running managers on a Rule 144A/Regulation S offering by TopBuild Escrow Corp., a wholly owned subsidiary of TopBuild Corp., of $400 million aggregate…
Davis Polk advised the initial purchasers in connection with the $300 million Regulation S offering by Central China Real Estate Limited of its 6.875% senior notes due 2020.
CCRE…
Davis Polk advised the initial purchasers in connection with a $500 million Regulation S offering by CIFI Holdings (Group) Co. Ltd. of its 6.875% senior notes due 2021.
Established in…
Davis Polk advised the initial purchasers in connection with the Regulation S offering by Yanlord Land (HK) Co., Limited of its $350 million 6.75% senior notes due 2023, which are…
Davis Polk advised the initial purchasers in connection with a $600 million Regulation S only offering by China SCE Property Holdings Limited of its 7.45% senior notes due 2021.
China…
Davis Polk advised the initial purchaser in connection with the offering by Hilton Domestic Operating Company Inc., an indirect subsidiary of Hilton Worldwide Holdings Inc., of $1.5…
Davis Polk advised the joint book-running managers on a Rule 144A / Regulation S offering by Wyndham Hotels & Resorts, Inc. of $500 million aggregate principal amount of 5.375%…
Davis Polk advised the representatives of the several initial purchasers in connection with a Rule 144A/Regulation S offering by Coty Inc. of $550 million aggregate principal amount of…
Davis Polk advised Charles River Laboratories International, Inc. in connection with its Rule 144A/Regulation S offering of $500 million aggregate principal amount of 5.500% senior notes…
Davis Polk advised Valeant Pharmaceuticals International, Inc. (“Valeant”) in connection with a refinancing transaction pursuant to which its indirect wholly owned subsidiary, Valeant…